As we have previously reported, DePuy Orthopedics, Inc., was involved in detailed settlement discussions to resolve thousands of lawsuits involving its ASR hip device. The cases, centralized in federal court as part of a multi-district litigation (“MDL”) and centralized in New Jersey state court, may soon resolve for those plaintiffs who underwent revision surgery.

As we have previously reported, DePuy Orthopaedics, Inc. has recalled its ASR hip replacement device. There are thousands of cases pending across the country related to the ASR device. These cases continue to proceed in state and federal courts.

The New York Times reports that DePuy Orthopaedics, Inc., a subsidiary of Johnson & Johnson,

As we have previously reported, there are over 10,000 lawsuits pending nationwide against Johnson & Johnson for its metal-on-metal hip replacements, the DePuy Pinnacle and the DePuy ASR. Plaintiffs allege that the metal-on-metal hip replacement devices have a higher-than-normal failure rate. Additionally, some plaintiffs have complained that the device has caused metal poisoning, called

As we have previously reported, DePuy Orthopaedics, Inc. has recalled its ASR hip replacement device. There are thousands of cases pending across the country related to the ASR device. These cases continue to proceed in state and federal courts.

The cases currently pending in Bergen County, New Jersey continue to move closer to trial.

Currently, there are more than 10,000 lawsuits pending nationwide against Johnson & Johnson for its metal-on-metal hip replacements, the DePuy Pinnacle and the DePuy ASR. Plaintiffs allege that the metal-on-metal hip replacement devices have a higher-than-normal failure rate. Additionally, some plaintiffs have complained that the device has caused metal poisoning, called metallosis, due to high